[HTML][HTML] Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - Nature Reviews Immunology, 2021 - nature.com
The identification of elevated IL-6 levels in patients with severe COVID-19 led to the rapid
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - Nature reviews. Immunology, 2021 - europepmc.org
The identification of elevated IL-6 levels in patients with severe COVID-19 led to the rapid
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
[HTML][HTML] Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - Nature Reviews. Immunology, 2021 - ncbi.nlm.nih.gov
The identification of elevated IL-6 levels in patients with severe COVID-19 led to the rapid
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - Nature Reviews Immunology, 2021 - orca.cardiff.ac.uk
The identification of elevated IL-6 levels in patients with severe COVID-19 led to the rapid
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
[PDF][PDF] Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - researchgate.net
The identification of elevated IL-6 levels in patients with severe COVID-19 led to the rapid
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - Nature reviews. Immunology, 2021 - pubmed.ncbi.nlm.nih.gov
The identification of elevated IL-6 levels in patients with severe COVID-19 led to the rapid
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
[引用][C] Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - Nature Reviews Immunology, 2021 - cir.nii.ac.jp
Is IL-6 a key cytokine target for therapy in COVID-19? | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Is IL-6 a key cytokine target for therapy in COVID-19?
SA Jones, CA Hunter - Nature reviews. Immunology, 2021 - europepmc.org
The identification of elevated IL-6 levels in patients with severe COVID-19 led to the rapid
development of clinical trials targeting this cytokine. Overall, these trials do not support the …
development of clinical trials targeting this cytokine. Overall, these trials do not support the …